Myocardial contrast echocardiography a 25-year retrospective

Circulation

Volumn 118, Issue 3, 2008, Pages 291-308

  Kaul, Sanjiv ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Contrast media; Coronary disease; Echocardiography; Imaging

Indexed keywords

ALBUNEX; ATROPINE; CARDIOSPHERE; CONTRAST MEDIUM; CP 4715; DIPYRIDAMOLE; DOBUTAMINE; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; FLUOROCARBON; PERFLEXANE; PERFLUBUTANE; PERFLUTREN; PHENYLEPHRINE; PHTHALIC ACID DIMETHYL ESTER; SHU 508; SONOVUE; TECHNETIUM 99M; TIROFIBAN; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; BLOOD FLOW VELOCITY; CARDIOLOGY; CLINICAL RESEARCH; CLINICAL TRIAL; CONTRAST ECHOCARDIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DOG; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG INHIBITION; DRUG MEGADOSE; ELECTROCARDIOGRAM; EXERCISE TEST; GENE TARGETING; HEART MUSCLE; HUMAN; HYPOTENSION; IN VIVO STUDY; INJECTION; INTRACORONARY INFUSION; LOW DRUG DOSE; LUNG CIRCULATION; MICROBUBBLE; MOLECULAR IMAGING; MYOCARDIAL CONTRAST ECHOCARDIOGRAPHY; NONHUMAN; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RADIOSENSITIVITY; REFLEX TACHYCARDIA; REVIEW; SIGNAL PROCESSING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TISSUE PERFUSION; ACUTE DISEASE; ANIMAL; ARTICLE; CHRONIC DISEASE; ECHOCARDIOGRAPHY; ECHOGRAPHY; HISTORY; METHODOLOGY;

ACUTE CORONARY SYNDROME; ACUTE DISEASE; ANIMALS; CHRONIC DISEASE; CONTRAST MEDIA; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS;

EID: 49149094134     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.107.747303     Document Type: Review

References (122)

1. Kaul S. Myocardial contrast echocardiography: 15 years of research and development. Circulation. 1997;96:3745-3760.
2. Kaul S, Ito H. The microvasculature in acute myocardial ischemia: evolving concepts in pathophysiology, diagnosis, and treatment, part I. Circulation. 2003;109:146-149.
3. Kaul S, Ito H. The microvasculature in acute myocardial ischemia: evolving concepts in pathophysiology, diagnosis, and treatment, part II. Circulation. 2003;109:310-315.
4. Armstrong WF, Mueller TM, Kinney EL, Tickner EG, Dillon JC, Feigenbaum H. Assessment of myocardial perfusion abnormalities with contrast-enhanced two-dimensional echocardiography. Circulation. 1982;66:166-173.
5. Kemper AJ, O'Boyle JE, Cohen CA, Taylor A, Parisi AF. Hydrogen peroxide contrast echocardiography: quantification in vivo of myo- cardial risk area during coronary occlusion and the necrotic area remaining after myocardial reperfusion. Circulation. 1984;70:309-317.
6. Kaul S, Pandian NG, Okada RD, Pohost GM, Weyman AE. Contrast echocardiography in acute myocardial ischemia, I: in-vivo determination of total left ventricular "area at risk." J Am Coll Cardiol. 1984;4: 1272-1282.
7. Kaul S, Pandian NG, Gillam LD, Newell JB, Okada RD, Weyman AE. Contrast echocardiography in acute myocardial ischemia, III: an in-vivo comparison of the extent of abnormal wall motion with the area at risk for necrosis. J Am Coll Cardiol. 1986;7:383-392.
8. Kaul S, Glasheen W, Ruddy TD, Pandian NG, Weyman AE, Okada RD. The importance of defining left ventricular 'area at risk' in-vivo during acute myocardial infarction: an experimental evaluation utilizing myocardial contrast 2D-echocardiography. Circulation. 1987;75:1249- 1260.
9. Kaul S, Pandian NG, Guerrero JL, Gillam LD, Okada RD, Weyman AE. Effects of selectively altering the collateral driving pressure on regional perfusion and function in the occluded coronary bed in the dog. Circ Res. 1987;61:77-85.
10. Feinstein SB, Ten Cate F, Zwehl W, Ong K, Maurer G, Tei C, Shah PM, Meerbaum S, Corday E. Two-dimensional contrast echocardiography, I: in vitro development and quantitative analysis of echo contrast agents. J Am Coll Cardiol. 1984;3:14-20.
11. Keller MW, Glasheen W, Teja K, Gear A, Kaul S. Myocardial contrast echocardiography without significant hemodynamic effects or reactive hyperemia: a major advantage in the imaging of myocardial perfusion. J Am Coll Cardiol. 1988;12:1039-1047.
12. Moore CA, Smucker ML, Kaul S. Myocardial contrast echocardiogra- phy in humans, I: safety: a comparison with routine coronary arteriography. J Am Coll Cardiol. 1986;8:1066-1072.
13. Keller MW, Glasheen WP, Smucker ML, Burwell LR, Watson DD, Kaul S. Myocardial contrast echocardiography in humans, II: assessment of coronary blood flow reserve. J Am Coll Cardiol. 1988; 12:924 -935.
14. Keller MW, Glasheen WP, Kaul S. Albunex: a safe and effective commercially produced agent for myocardial contrast echocardiography. J Am Soc Echocardiogr. 1989;2:48-52.
15. Lindner JR, Dent JM, Moos S, Jayaweera AR, Kaul S. Enhancement of left ventricular cavity opacification by harmonic imaging after venous injection of Albunex. Am J Cardiol. 1997;79:1657-1662.
16. Klibanov AL, Hughes MS, Wojdyta J, Wible J, Brandenburg G. Destruction of contrast agent microbubbles in the ultrasound field: the fate of microbubble shell and the importance of bubble gas content. Acad Radiol. 2002;9:S41-S45.
17. Postema H, vanWamel A, ten Cate FJ, de Jong N. High-speed photography during ultrasound illustrates potential therapeutic applications of microbubbles. Med Phys. 2005;32:3707-3711.
18. Skyba DM, Camarano G, Goodman NC, Price RJ, Skalak TC, Kaul S. Hemodynamic characteristics, myocardial kinetics, and microvascular rheology of FS-069, a second-generation echocardiographic contrast agent capable of producing myocardial opacification from a venous injection. J Am Coll Cardiol. 1996;28:1292-1300.
19. Lindner JR, Firschke C, Wei K, Goodman NC, Skyba DM, Kaul S. Myocardial perfusion characteristics and hemodynamic profile of MRX-115, a venous echocardiography contrast agent, during acute myocardial infarction. J Am Soc Echocardiogr. 1998;11:36-46.
20. Keller MW, Segal SS, Kaul S, Duling B. The behavior of sonicated albumin microbubbles within the microcirculation: a basis for their use during myocardial contrast echocardiography. Circ Res. 1989;65: 458-467.
21. Lindner JR, Song J, Jayaweera AR, Sklenar J, Kaul S. Microvascular rheology of Definity microbubbles after intra-arterial and intravenous administration. J Am Soc Echocardiogr. 2002;15:396-403.
22. Jayaweera AR, Edwards N, Glasheen WP, Villanueva FS, Abbott RD, Kaul S. In-vivo myocardial kinetics of air-filled albumin microbubbles during myocardial contrast echocardiography: comparison with radiolabeled red blood cells. Circ Res. 1994;74:1157-1165.
23. Wei K, Skyba DM, Firschke C, Lindner JR, Jayaweera AR, Kaul S. Interaction between microbubbles and ultrasound: in vitro and in vivo observations. J Am Coll Cardiol. 1997;29:1081-1088.
24. Uhlendorf V, Hoffman C. Nonlinear acoustical response of coated microbubbles in diagnostic ultrasound. IEEE Proc. 1994;3:1559 -1562.
25. Shi W, Forsberg F. Ultrasonic characterization of the nonlinear properties of contrast microbubbles. Ultrasound Med Biol. 2000;26:93-104.
26. Kaul S. Instrumentation for contrast echocardiography: technology and techniques. Am J Cardiol. 2002;90(suppl) 8J-14J.
27. Lindner JR, Villanueva FS, Dent JM, Wei K, Sklenar J, Kaul S. Assessment of resting perfusion with myocardial contrast echocardiography: theoretical and practical considerations. Am Heart J. 2000;139: 231-240.
28. Wei K, Jayaweera AR Firoozan S, Linka A, Skyba DM, Kaul S. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation. 1998;97:473-483.
29. Le DE, Bin JP, Coggins M, Linder J, Wei K, Kaul S. Relation between myocardial oxygen consumption and myocardial blood volume: a study using myocardial contrast echocardiography. J Am Soc Echocardiogr. 2002;15:857-863.
30. Toyota E, Fujimoto K, Ogasawara Y, Kajita T, Shigeto F, Matsumoto T, Goto M, Kajiya F. Dynamic changes in three-dimensional architecture and vascular volume of transmural coronary microvasculature between diastolic- and systolic-arrested rat hearts. Circulation. 2002;105: 621-626.
31. Vogel R, Indermuhle A, Reinhardt J, Meier P, Siegrist PT, Namdar M, Kaufmann PA, Seiler C. The quantification of absolute myocardial perfusion in humans by contrast echocardiography: algorithm and validation. J Am Coll Cardiol. 2005;45:754-762.
32. Jayaweera AR, Wei K, Coggins M, Bin JP, Goodman C, Kaul S. Role of capillaries in determining coronary blood flow reserve: new insights using myocardial contrast echocardiography. Am J Physiol. 1999;277: H2363-H2372.
33. 99mTc-sestamibi perfusion defects during pharmacologically induced coronary vasodilatation. Am J Physiol. 2001,280: H1896-H1904.
34. Bin JP, Le DE, Jayaweera AR, Coggins MP, Wei K, Kaul S. Direct effects of dobutamine on the coronary microcirculation: comparison with adenosine using myocardial contrast echocardiography. JAmSoc Echocardiogr. 2003;16:871-879.
35. Bin JP, Pelberg RA, Coggins MP, Wei K, Kaul S. Mechanism of inducible regional dysfunction during dipyridamole stress. Circulation. 2002;106:112-117.
36. Miszalski-Jamka T, Kuntz-Hehner S, Schmidt H, Hammerstingl C, Tiemann K, Ghanem A, Troatz C, Luderitz B, Omran H. Real time myocardial contrast echocardiography during supine bicycle stress and continuous infusion of contrast agent: cutoff values for myocardial contrast replenishment discriminating abnormal myocardial perfusion. Echocardiography. 2007;24:638-648.
37. Bin JP, Pelberg RA, Wei K, Le DE, Goodman NC, Kaul S. Dobutamine versus dipyridamole for inducing reversible perfusion defects in chronic multivessel coronary artery stenosis. J Am Coll Cardiol. 2002;40: 167-174.
38. Ito H, Tomooka T, Sakai N, Yu H, Higashino Y, Fujii K, Masuyama T, Kitabatake A, Minamino T. Lack of myocardial perfusion immediately after successful thrombolysis: a predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation. 1992;85: 1699 -1705.
39. Ito H, Maruyama A, Iwakura K, Takiuchi S, Masuyama T, Hori M, Higashino Y, Fujii K, Minamino T. Clinical implications of the "no reflow" phenomenon: a predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation. 1996;93: 223-228.
40. Ragosta M, Camarano GP, Kaul S, Powers E, Sarembock IJ, Gimple LW. Microvascular integrity indicates myocellular viability in patients with recent myocardial infarction: new insights using myocardial contrast echocardiography. Circulation. 1994;89:2562-2569.
41. Sakuma T, Hayashi Y, Sumii K, Imazu M, Yamakido M. Prediction of short- and intermediate-term prognoses of patients with acute myo- cardial infarction using myocardial contrast echocardiography one day after recanalization. J Am Coll Cardiol. 1998;32:890-897.
42. Villanueva FS, Glasheen WP, Sklenar J, Kaul S. Characterization of spatial patterns of flow within the reperfused myocardium using myo- cardial contrast echocardiography: implications in determining the extent of myocardial salvage. Circulation. 1993;88:2596-2606.
43. Villanueva FS, Camarano G, Ismail S, Goodman NC, Sklenar J, Kaul S. Coronary reserve abnormalities during post-infarct reperfusion: implications for the timing of myocardial contrast echocardiography to assess myocardial viability. Circulation. 1996;94:748-754.
44. Sabia PJ, Powers ER, Ragosta M, Sarembock IJ, Burwell LR, Kaul S. An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction. N Engl J Med. 1992;372: 1825-1831.
45. Sabia PJ, Powers ER, Jayaweera AR, Ragosta M, Kaul S. Functional significance of collateral blood flow in patients with recent acute myocardial infarction: a study using myocardial contrast echocardiography. Circulation. 1992;85:2080-2089.
46. Coggins MP, Le DE, Wei K, Goodman NC, Lindner JR, Kaul S. Noninvasive prediction of ultimate infarct size at the time of acute coronary occlusion based on the extent and magnitude of collateral- derived myocardial blood flow. Circulation. 2001;104:2471-2477.
47. Janardhanan R, Swinburn JM, Greaves K, Senior R. Usefulness of myocardial contrast echocardiography using low-power continuous imaging early after acute myocardial infarction to predict late functional left ventricular recovery. Am J Cardiol. 2003;92:493-497.
48. Dwivedi G, Janardhanan R, Hayat SA, Swinburn JA, Senior R. Prognostic value of myocardial viability detected by myocardial contrast echocardiography early after acute myocardial infarction. J Am Coll Cardiol. 2007;50:327-334.
49. Hayat SA, Janardhanan R, Moon JC, Pennell DJ, Senior R. Comparison between myocardial contrast echocardiography and single-photon emission computed tomography for predicting transmurality of acute myocardial infarction. Am J Cardiol. 2006;97:1718 -1721.
50. Rovai D, Zanchi M, Lombardi M, Magagnini E, Chella P, Pieroni A, Picano E, Ferdeghini M, Morris H, Distante A, L'Abbate A. Residual myocardial perfusion in reversibly damaged myocardium by dipyridamole contrast echocardiography. Eur Heart J. 2006;17:296-301.
51. Galiuto L, Gabrielli FA, Lombardo A, La Torre G, Scara A, Rebuzzi AG, Crea F. Reversible microvascular dysfunction coupled with persistent myocardial dysfunction: implications for post-infarct left ventricular remodelling. Heart. 2007;93:565-571.
52. Ujino K, Hillis GS, Mulvagh SL, Hagen ME, Oh JK. Usefulness of
53. real-time intravenous myocardial contrast echocardiography in predicting left ventricular dilation after successfully reperfused acute myocardial infarction. Am J Cardiol. 2005;96:17-21.
54. Scherrer-Crosbie M, Liel-Cohen N, Otsuji Y, Guerrero JL, Sullivan S, Levine RA, Picard MH. Myocardial perfusion and wall motion in infarction border zone: assessment by myocardial contrast echocardiog- raphy. J Am Soc Echocardiogr. 2000;13:353-357.
55. Leong-Poi H, Coggins M, Sklenar J, Jayaweera AR, Wang X, Kaul S. Role of collateral blood flow in the apparent disparity between the extent of abnormal wall thickening and perfusion defect size during acute myocardial infarction and demand ischemia. J Am Coll Cardiol. 2005; 45:565-572.
56. Kaul S, Senior R, Firschke C, Wang X, Lindner JR, Villanueva FS, Kontos MC, Taylor A, Nixon JV, Watson DD, Harrell FE. Incremental value of cardiac imaging in patients presenting to the emergency department with chest pain and without ST-segment elevation: a multicenter study. Am Heart J. 2004;148:129-136.
57. Korosoglou G, Labadze N, Hansen A, Selter C, Giannitsis E, Katus H, Kuecherer H. Usefulness of real-time myocardial perfusion imaging in the evaluation of patients with first time chest pain. Am J Cardiol. 2004;94:1225-1231.
58. Rinkevich D, Kaul S, Wang X-Q, Tong KL, Belcik T, Kalvaitis S, Lepper W, Foster WA, Wei K. Incremental value of regional perfusion over regional function in patients presenting to the emergency department with suspected cardiac chest pain and non-diagnostic electrocardiographic changes. Eur Heart J. 2005;26:1606-1611.
59. Tong KL, Kaul S, Wang X, Rinkevich A, Kalvaitis S, Belcik T, Lepper W, Foster WA, Wei K. Myocardial contrast echocardiography provides superior and rapid prognostic information compared to routine assessment in patients presenting with chest pain to the emergency department. J Am Coll Cardiol. 2005;46:920-927.
60. Senior R, Ashrafian H. Detecting acute coronary syndrome in the emergency department: the answer is in seeing the heart: why look further? Eur Heart J. 2005;26:1606-1611.
61. Vannan MA, Narula J. Ischemic versus nonischemic chest pain in the emergency room. J Am Coll Cardiol. 2005;46:928-929.
62. Ramakrishna G, Ravi BS, Chandrasekaran K. Apical ballooning syndrome in a postoperative patient with normal microvascular perfusion by myocardial contrast echocardiography. Echocardiography. 2005;22:606-610.
63. Ismail S, Jayaweera AR, Goodman NC, Camarano GP, Skyba DM, Kaul S. Detection of coronary artery stenoses and quantification of blood flow mismatch during coronary hyperemia with myocardial contrast echocardiography. Circulation. 1995;91:821-830.
64. Firschke C, Lindner JR, Wei K, Skyba D, Goodman NC, Kaul S. Myocardial perfusion imaging in the setting of coronary artery stenosis and acute myocardial infarction using venous injection of FS-069, a
65. second generation echocardiographic contrast agent. Circulation. 1997; 96:959-967.
66. Wei K, Jayaweera AR, Firoozan S, Linka A, Skyba DM, Kaul S. Basis for stenosis detection using venous administration of microbubbles during myocardial contrast echocardiography: bolus or continuous infusion? J Am Coll Cardiol. 1998;32:252-260.
67. 99mTc-sestamibi single photon emission computed tomography. Circulation. 1997;96:785-792.
68. Porter TR, Li S, Jiang L, Grayburn P, Deligonul U. Real-time visualization of myocardial perfusion and wall thickening in human beings with intravenous ultrasonographic contrast and accelerated intermittent harmonic imaging. J Am Soc Echocardiogr. 1999;12:266-271.
69. Wei K, Ragosta M, Thorpe J, Moos S, Kaul S. Noninvasive measurement of coronary blood flow reserve myocardial contrast echocar- diography. Circulation. 2001;103:2560-2565.
70. 99mTc-SPECT. Am Heart J. 2004;147:1100-1105.
71. Jeetley P, Hickman M, Kamp O, Lang RM, Thomas JD, Vannan MA, Vanoverschelde JL, van der Wouw PA, Senior R. Myocardial contrast echocardiography for the detection of coronary artery stenosis: a prospective multicenter study in comparison with single-photon emission computed tomography. J Am Coll Cardiol. 2006;47:141-145.
72. Dijkmans PA, Senior R, Becher H, Porter TR, Wei K, Visser CA, MD, Kamp O. Myocardial contrast echocardiography evolving as a clinically feasible technique for accurate, rapid, and safe assessment of myocardial perfusion: the evidence so far. J Am Coll Cardiol. 2006;48:2168 -2177.
73. Senior R, Zabalgoita M, Monaghan M, Main M, Zamarano JL, Tiemann K, Agati L, Weissman NJ, Klein AL, Marwick TH, Ahmad M, DeMaria AN, Becher H, Kaul S, Udelson JE, Wackers FJ, Walvovitch RC, Picard MH. Accurate detection of coronary artery disease by echocardiography using perflubutane polymer microspheres, a novel contrast agent: comparison with nuclear perfusion imaging in two phase three multicenter clinical trials. Circulation. 2007;116:II-546. Abstract.
74. Bin JP, Pelberg RA, Coggins MP, Wei K, Kaul S. Mechanism of inducible regional dysfunction during dipyridamole stress. Circulation. 2002;106:112-117.
75. Firschke C, Andrassy P, Linka AZ, Busch R, Martinoff S. Adenosine myocardial contrast echo in intermediate severity coronary stenoses: a prospective two-center study. Int J Cardiovasc Imaging. 2007;23: 311-321.
76. Hauser AM, Vellappillil G, Ramos RG, Gordon S, Timmis GC. Sequence of mechanical, electrocardiographic and clinical effects of repeated coronary artery occlusion in human beings: echocardiographic observations during coronary angioplasty. J Am Coll Cardiol. 1985;5: 193-197.
77. Leong-Poi H, Rim S-J, Le ED, Fisher NG, Wei K, Kaul S. Perfusion versus function: the ischemic cascade in demand ischemia: implications of single- versus multivessel stenosis. Circulation. 2002;105:987-992.
78. Elhendy A, O'Leary EL, Xie F, McGrain AC, Anderson JR, Porter TR. Comparative accuracy of real-time myocardial contrast perfusion imaging and wall motion analysis during dobutamine stress echocardiography for the diagnosis of coronary artery disease. J Am Coll Cardiol. 2004;44:2185-2191.
79. Elhendy A, Tsutsui JM, O'Leary EL, Xie F, McGrain AC, Porter TR. Noninvasive diagnosis of coronary artery disease in patients with diabetes by dobutamine stress real-time myocardial contrast perfusion imaging. Diabetes Care. 2005;28:1662-1667.
80. Tsutsui JM, Elhendy A, Anderson JR, Xie F, McGrain AC, Porter TR. Prognostic value of dobutamine stress myocardial contrast perfusion echocardiography. Circulation. 2005;112:1444-1450.
81. Tsutsui JM, Xie F, Cloutier D, Kalvaitis S, Elhendy A, Porter TR. Real-time dobutamine stress myocardial perfusion echocardiography predicts outcome in the elderly. Eur Heart J. 2008;29:377-385.
82. Dodla S, Xie F, Cory B, Stevens RB, O'Leary E, Porter TR. Prognostic value and angiographic correlation of dobutamine stress imaging with real time perfusion echocardiography in asymptomatic diabetic patients undergoing pre-operative evaluation. J Am Soc Echocardiogr. 2007; 20:564. Abstract.
83. Moir S, Haluska B, Jenkins C, McNab D, Marwick TH. Comparison of specificity of quantitative myocardial contrast echocardiography for diagnosis of coronary artery disease in patients with versus without diabetes mellitus. Am J Cardiol. 2005;96:187-192.
84. Tsutsui JM, Mukherjee S, Elhendy A, Xie F, Lyden ER, O'Leary E, McGrain AC, Porter TR. Value of dobutamine stress myocardial contrast perfusion echocardiography in patients with advanced liver disease. Liver Transplantation. 2006;12:592-599.
85. Lindner JR, Skyba DM, Goodman NC, Jayaweera AR, Kaul S. Changes in myocardial blood volume with graded coronary stenosis: an experimental evaluation using myocardial contrast echocardiography. Am J Physiol. 1997;272:H567-H575.
86. Wei K, Le E, Bin JP, Jayaweera AR, Goodman NC, Kaul S. Noninvasive detection of coronary artery stenosis at rest without recourse to exercise or pharmacologic stress. Circulation. 2002;105:218 -223.
87. Wei K, Tong KL, Belcik T, Rafter P, Ragosta M, Kaul S. Detection of non-critical coronary stenosis at rest with myocardial contrast echocardiography. Circulation. 2005;112:1154-1160.
88. Grayburn PA. Stress echo without the stress: detection of coronary stenosis at rest by myocardial contrast echocardiography. Circulation. 2005;112:1085-1087.
89. Pascotto M, Wei K, Micari A, Bragadeesh T, Goodman NC, Kaul S. Phasic changes in myocardial blood volume are influenced by collateral blood flow: implications for the quantification of coronary stenosis at rest. Heart. 2007;93:438-443.
90. Shimoni S, Fangogiannis NG, Aggeli CJ, Shan K, Verani MS, Quinones MA, Espada R, Letsou GV, Lawrie GM, Winters WL, Reardon MJ, Zoghbi WA. Identification of hibernating myocardium with quantitative intravenous myocardial contrast echocardiography comparison with dobutamine echocardiography and thallium-201 scintigraphy. Circulation. 2003;107:538-544.
91. Shimoni S, Frangogiannis NG, Aggeli CJ, MD, Shan K, Quinones MA, Espada R, Letsou GV, Lawrie GM, Winters WL, Reardon MJ, Zoghbi WA. Microvascular structural correlates of myocardial contrast echocardiography in patients with coronary artery disease and left ventricular dysfunction implications for the assessment of myocardial hibernation. Circulation. 2002;106:950-956.
92. Senior R, Janardhanan R, Jeetley P, Burden L. Myocardial contrast echocardiography for distinguishing ischemic from nonischemic first-onset acute heart failure insights into the mechanism of acute heart failure. Circulation. 2005;112:1587-1593.
93. Keller MW, Spotnitz WD, Matthew TL, Glasheen WP, Watson DD, Kaul S. Intraoperative assessment of regional myocardial perfusion using quantitative myocardial contrast echocardiography: an experimental evaluation. J Am Coll Cardiol. 1990;16:1267-1279.
94. Villanueva FS, Spotnitz WD, Jayaweera AR, Gimple LW, Dent J, Kaul S. On-line intraoperative quantitation of regional myocardial perfusion during coronary artery bypass graft operations with myocardial contrast two-dimensional echocardiography. J Thorac Cardiovasc Surg. 1992; 104:1524-1531.
95. Bayfield M, Lindner JR, Kaul S, Ismail S, Goodman NC, Spotnitz WD. Deoxygenated blood minimizes adherence of sonicated albumin microbubbles during cardioplegic arrest and after blood reperfusion: experimental and clinical observations with myocardial contrast echocardiography. J Thorac Cardiovasc Surg. 1997;113:1100-1108.
96. Lindner JR, Coggins MP, Kaul S, Klibanov AL, Brandenburger GH, Ley K. Microbubble persistence in the microcirculation during ischemia-reperfusion and inflammation is caused by integrin- and complement-mediated adherence to activated leukocytes. Circulation. 2000;101:668-675.
97. Leong-Poi H, Christiansen J, Klibanov AL, Kaul S, Lindner JR. Noninvasive assessment of angiogenesis by molecular imaging with ultrasound and microbubbles targeted to 0 integrins. Circulation. 2003; 107:455-460.
98. Ellegala DB, Leong-Poi H, Carpenter JE, Klibanov AL, Kaul S, Shaffrey ME, Sklenar J, Lindner JR. Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to αv,β3. Circulation. 2003;108:336-341.
99. ]97. Weller GER, Wong MKK, Modzelewski RA, Lu E, Klibanov AL, Wagner WR, Villanueva FS. Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine-arginine-leucine. Cancer Res. 2005;65:533-539.
100. Villanueva FS, Jankowski RJ, Klibanov S, Pina ML, Alber SM, Watkins SC, Brandenburger GH, Wagner WR. Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells. Circulation. 1998;98:1-5.
101. Weller GER, Lu E, Csikari MM, Klibanov AL, Fischer D, Wagner WR, Villanueva FS. Ultrasound imaging of acute cardiac transplant rejection with microbubbles targeted to intercellular adhesion molecule-1. Circulation. 2003;108:218-224.
102. Lindner JR, Dayton PA, Coogins MP, Ley K, Song J, Ferrara K, Kaul S. Noninvasive imaging of inflammation by ultrasound detection of phagocytosed microbubbles. Circulation. 2000;102:531-538.
103. Lindner JR, Song J, Xu F, Klibanov AL, Singbartl K, Ley K, Kaul S. Noninvasive ultrasound imaging of inflammation using microbubbles targeted to activated leukocytes. Circulation. 2000;102:2745-2750.
104. Christiansen JP, Leong-Poi H, Klibanov AL, Kaul S, Lindner JR. Non- invasive imaging of myocardial reperfusion injury using leukocyte- targeted contrast echocardiography. Circulation. 2002;105:1764-1767.
105. Schumann P, Christiansen JP, Quigley RM, McCreery TP, Sweitzer RH, Unger EC, Lindner JR, Matsunaga TO. Targeted-microbubble binding selectively to GPIIb IIIa receptors of platelet thrombi. Invest Radiol. 2002;37:587-593.
106. Sakuma T, Sklenar J, Leong-Poi H, Goodman NC, Glover DK, Kaul S. Molecular imaging identifies regions with microthromboemboli during primary angioplasty in acute coronary thrombosis. J Nucl Med. 2004; 45:1194-1200.
107. Villanueva FS, Lu E, MD, Bowry S, Kilic S, Tom E, Wang J, Gretton J, Pacella JJ, Wagner WR. Myocardial ischemic memory imaging with molecular echocardiography. Circulation. 2007;115:345-352.
108. Kaufmann B, Lewis C, Xie A, Mirza-Mohd A, Lindner JR. Detection of recent myocardial ischaemia by molecular imaging of P-selectin with targeted contrast echocardiography. Eur Heart J. 2007;28:2011-2017.
109. Kaufmann BA, Sanders JM, Davis C, Xie A, Aldred P, Sarembock IJ, Lindner JR. Molecular imaging of inflammation in atherosclerosis with targeted ultrasound detection of vascular cell adhesion molecule-1. Circulation. 2007;116:276-284.
110. Anderson DR, Tsutsui JM, Xie F, Radio SJ, Porter TR. The role of complement in the adherence of microbubbles to dysfunctional arterial endothelium and atherosclerotic plaque. Cardiovasc Res. 2007;73: 597-606.
111. 3 and Ilb/IIIa inhibition causes a marked reduction in infarct size following reperfusion in a canine model of acute coronary thrombosis: utility of in-vivo molecular imaging with myocardial contrast echocardiography. Cardiovasc Res. 2005;66:552-561.
112. Nagueh SF, Lakkis NM, Zuo-Xiang H, Middleton KJ, Killip A, Zoghbi WA, Quinones MA, Roberts E, Verani MS, Kleiman NS. Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. JAm Coll Cardiol. 1998;32:225-229.
113. Masugata H, Fujita N, Kondo I, Peters B, Ohmori K, Mizushige K, Kohno M, DeMaria AN. Assessment of right ventricular perfusion after right coronary artery occlusion by myocardial contrast echocardiography. J Am Coll Cardiol. 2003;41:1823-1830.
114. Wolf D, Reinhard A, Krause U, Seckinger A, Katus HA, Kuecherer H, Hansen A. Stem cell therapy improves myocardial perfusion and cardiac synchronicity: new application for echocardiography. J Am Soc Echocardiogr. 2007;20:512-520.
115. Kirkpatrick JN, Wong T, Bednarz JE, Spencer KT, Sugeng L, Ward RP, DeCara JM, Weinert L, Krausz T, Lang RM. Differential diagnosis of cardiac masses using contrast echocardiographic perfusion imaging. J Am Coll Cardiol. 2004;43:1412-1419.
116. Hayat SA, Dwivedi G, Jacobson A, Kinsey C, Senior R. Effects of left bundle branch block on cardiac structure, function, perfusion and perfusion reserve: implications for myocardial contrast echocardiography versus radionuclide perfusion imaging for the detection of coronary artery disease. Circulation. 2008;117:1832-1841.
117. Micari A, Pascotto M, Jayaweera AR, Sklenar J, Goodman NC, Kaul S. Cyclic variation in ultrasonic myocardial integrated backscatter is due to phasic changes in myocardial microvascular dimensions. J Ultrasound Med. 2006;25:1009-1019.
118. Thibault H, Lafitte S, Timperley J, Tariosse L, Becher H, Roudaut R. Dos Santos P. Quantitative analysis of myocardial perfusion in rats by contrast echocardiography. J Am Soc Echocardiogr. 2005;18: 1321-1328.
119. Kaufmann BA, Lankford M, Behm CZ, French BA, Klibanov AL, Xu Y, Lindner JR. High-resolution myocardial perfusion imaging in mice with high-frequency echocardiographic detection of a depot contrast agent. J Am Soc Echocardiogr. 2007;20:136-43.
120. Rim S-J, Leong-Poi H, Lindner JR, Wei K, Fisher NG, Kaul S. The decrease in coronary blood flow reserve during hyperlipidemia is secondary to an increase in blood viscosity. Circulation. 2001;104: 2704-2709.
121. Bin JP, Doctor A, Lindner JR, Leong-Poi H, Fisher NG, Le ED, Hendersen EH, Christiansen J, Kaul S. Effects of nitroglycerin on erythrocyte rheology and oxygen unloading: novel role of S-nitrosohemoglobin in relieving myocardial ischemia. Circulation. 2006;113:2502-2508.
122. Le DE, Jayaweera AR, Wei K, Coggins MP, Lindner JR, Kaul S. Changes in myocardial blood volume over a wide range of coronary driving pressures: role of capillaries beyond the autoregulatory range. Heart. 2004;90:1199-1205.